Literature DB >> 32284640

Balancing risks and benefits of artificial intelligence in the health sector.

Kenneth Goodman1, Diana Zandi2, Andreas Reis3, Effy Vayena4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32284640      PMCID: PMC7133475          DOI: 10.2471/BLT.20.253823

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


× No keyword cloud information.
During the last decade, enhanced computing power and the availability of large amounts of data have prompted the practical use of artificial intelligence in health care. Health and medical journals now commonly include reports on machine learning and big data, and descriptions of the risks posed by, and the governance required to manage, this technology. Machine learning algorithms are used to make diagnoses, identify treatments and analyse public health threats, and these systems can learn and improve continuously in response to new data. The tension between risks and concerns on one hand versus potential and opportunity on the other has shaped this issue of the Bulletin of the World Health Organization on the new ethical challenges of artificial intelligence in public health. Data-driven discovery and analysis in health care can increase knowledge and efficiency as well as challenge social values related to privacy, data control and the monetization of personal information. In India, for example, the adoption of a system for assigning all citizens a unique identification number, linking it to individual health records and several health-related schemes, raises ethical, legal and social issues, and the need for an appropriate ethical framework and data governance. These issues might be particularly challenging in low- and middle-income countries. Trust is perhaps the overarching theme of the contributions to this issue, and it is indeed one of the central values in digital health. One article explores opportunities for a human-centric ethical and regulatory environment to support the evolution of trust-based artificial intelligence with special regard to health insurance. Likewise, trust plays a role along with empathy and compassion in the humane side of care, the importance of which must be preserved in exploring the kind of health care society ought to promote. Similarly, European Union guidance might be too context-specific and as such leaves too much room for local, contextualized discretion for it to foster trustworthy artificial intelligence globally. In the context of population health research, researchers propose a post-research review model for ethics governance of research using artificial intelligence. For mobile health research in behavioural science, machine learning tools pose novel challenges for transparency, privacy, consent and the management of adverse events, all of which point to the need for consensus-based guidelines. As use of artificial intelligence systems expands, accountability for harm to patients and responsibility for their safety entail the need for human control and understanding of these systems. Other safeguards will require deliberate investments in data quality, access to care and processes to minimize bias, all in the service of trustworthiness. Success in integrating artificial intelligence into everyday patient care, as for instance in the United Kingdom of Great Britain and Northern Ireland’s National Health Service, is dependent on transparency, accountability and trust. In addition to trust, the values of fairness, justice and equity are seen as posing challenges even if other ethical duties are met. If artificial intelligence systems can explicitly improve equity, it is also a requirement that they do not worsen inequity. Thus, the case of neglected tropical diseases in low-resource settings illustrates opportunities for improved public health, as well as new challenges. Globally, the potential to help address some shortages and unmet needs in public health and care services might be realized by artificial intelligence-controlled conversational agents or chatbots that give health advice. However, realizing this potential will require the collaborative establishment of best practices and international ethics guidelines for technologies that replace humans. The field of bioethics emerged and grew in response to the development of new technologies and, sometimes, related wrongdoing. Ensuring adequate education, governance and ongoing ethical scrutiny will be essential if we are to realize the benefits and minimize the risks of this new technology. Questions of artificial intelligence accountability, equity and inclusiveness remain. The field is quickly evolving, and more artificial intelligence-based applications and services are becoming available in high-income countries. Identifying better tools for benefit-sharing and, simultaneously, evidence-based safeguards and criteria for appropriate uses and users to benefit everyone, including those in middle- and low-income countries, is essential. The World Health Organization (WHO) has made a commitment to addressing ethics, governance and regulation of artificial intelligence for health. In late 2019, WHO established an expert group to help develop a global framework for ethics and governance in artificial intelligence. The goal of this initiative is to ensure that these technologies are aligned with the overarching aims of promoting fair and equitable global health, meeting human rights standards and supporting Member States’ commitments to achieve universal health coverage.
  4 in total

1.  5G, Big Data, and AI for Smart City and Prevention of Virus Infection.

Authors:  Shumin Ren; Bairong Shen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Heralding the Digitalization of Life in Post-Pandemic East Asian Societies.

Authors:  Calvin Wai-Loon Ho; Karel Caals; Haihong Zhang
Journal:  J Bioeth Inq       Date:  2020-11-09       Impact factor: 1.352

Review 3.  Using artificial intelligence for diabetic retinopathy screening: Policy implications.

Authors:  Rajiv Raman; Debarati Dasgupta; Kim Ramasamy; Ronnie George; Viswanathan Mohan; Daniel Ting
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

Review 4.  The prospective of Artificial Intelligence in COVID-19 Pandemic.

Authors:  Swati Swayamsiddha; Kumar Prashant; Devansh Shaw; Chandana Mohanty
Journal:  Health Technol (Berl)       Date:  2021-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.